Markus Krupp

Q: What is Markus Krupp email address?

Email Markus Krupp at markus.krupp@biontech.de. This email is the most updated Markus Krupp's email found in 2026.

Q: How to contact Markus Krupp?

To contact Markus Krupp send an email to markus.krupp@biontech.de. (updated on February 24, 2025)

Head of Safety Analyses and Signal Management at BioNTech SE | Frankfurt Rhine-Main Metropolitan Area

About Markus Krupp

Markus Krupp currently serves as the Head of Safety Analyses and Signal Management at BioNTech SE, where he plays a pivotal role in ensuring the integrity and reliability of the company's pharmacovigilance processes. In this capacity, Markus oversees the end-to-end management of safety signals, leveraging his extensive expertise in bioinformatics, biomedical sciences, and data science to enhance signal detection and evaluation. His leadership ensures that BioNTech remains compliant with stringent regulatory standards, including FDA Good Pharmacovigilance Practices (GVP), ICH guidelines, and EU GVP Modules IX, V, and XVI, thereby safeguarding patient safety and maintaining regulatory trust.

A key aspect of Markus’s role involves implementing advanced IT systems and high-performance computing solutions to facilitate real-time data analysis across large-scale datasets, including genomics, transcriptomics, and other omics data. His proficiency in programming languages and big data analytics enables the integration of complex biomedical data streams, supporting proactive safety monitoring and early signal detection. Markus also leads cross-functional teams in managing safety systems, ensuring the deployment of innovative tools for signal prioritization, data visualization, and automated reporting.

His strategic focus extends to fostering collaboration with governance bodies, regulatory agencies, and independent safety monitoring boards, providing expert insights to inform decision-making processes. Through his leadership, BioNTech’s safety signal management process exemplifies best practices in pharmacovigilance, combining cutting-edge data science with regulatory expertise to uphold the highest standards of patient safety and product quality in the rapidly evolving landscape of personalized cancer immunotherapies and mRNA-based vaccines.

Markus Krupp Work